Grabiec AM et al. |
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. |
2012 |
Ann. Rheum. Dis. |
pmid:21953341
|
Iliopoulos D et al. |
Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. |
2007 |
Ann. Rheum. Dis. |
pmid:17502362
|
Liu S et al. |
Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. |
2013 |
Ann. Surg. Oncol. |
pmid:22752337
|
Mukhopadhyay NK et al. |
Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. |
2006 |
Ann. Thorac. Surg. |
pmid:16488717
|
Swanson S |
Invited commentary. |
2006 |
Ann. Thorac. Surg. |
pmid:16488718
|
Chen Z et al. |
Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment. |
2015 |
Anticancer Agents Med Chem |
pmid:25991546
|
Rahim R and Strobl JS |
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. |
2009 |
Anticancer Drugs |
pmid:19584707
|
Hong S et al. |
Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. |
2007 |
Anticancer Drugs |
pmid:17704650
|
Monks A et al. |
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts. |
2009 |
Anticancer Drugs |
pmid:19606018
|
Wittich S et al. |
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. |
2005 |
Anticancer Drugs |
pmid:15930892
|
Arany I et al. |
Epigenetic modifiers exert renal toxicity through induction of p66shc. |
2011 |
Anticancer Res. |
pmid:21965735
|
Shu ST et al. |
Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. |
2010 |
Anticancer Res. |
pmid:20651337
|
Dressel U et al. |
Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. |
2000 Mar-Apr |
Anticancer Res. |
pmid:10810390
|
Yasuda K et al. |
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225573
|
Kuwajima A et al. |
The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225587
|
Jasek E et al. |
Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. |
2012 |
Anticancer Res. |
pmid:22753739
|
Nadasi E et al. |
Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. |
2009 |
Anticancer Res. |
pmid:19528494
|
Jung AR et al. |
Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. |
2013 |
Anticancer Res. |
pmid:23482750
|
Yap OW et al. |
Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. |
2009 |
Anticancer Res. |
pmid:19331143
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|